|
List
by Protocol Number
Informational
NCCTG N0392
Consent
HIPAA
Protocol
Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG
Clinical Trials
NCCTG N08C1 Consent
HIPAA
Protocol
(Arm B closed) (Arm
C closed
except for minorities)
Paclitaxel-Associated
Acute Pain Syndrome Natural History Study
Symptom Management
Neuropathy
N08CA Consent
HIPAA
Protocol
The Use of Glutathione (GSH) for Prevention of
TAXOL/CBDCA Induced Peripheral Neuropathy: A
Phase III Randomized, Double-Blind Placebo
Controlled Study
CTSU C170601
Consent
HIPAA
Protocol
Phase III Double Blind Trial of Oral Duloxetine
for Treatment of Pain Associated with
Chemotherapy-Induced Peripheral Neuropathy
SWOG S0715
Consent
HIPAA
Protocol
Randomized
Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane-Induced
Neuropathy
Nausea/vomiting
NCCTG N08C2 Consent
HIPAA
Protocol
A Pilot Phase II Randomized Double Blind Trial
of Palonosetron vs Placebo to Prevent Radiation
Therapy Induced Nausea and Vomiting
NCCTG N08C3
Consent
HIPAA
Protocol
Phase III
Double-Blind, Placebo-Controlled Study of
Gabapentin for the Prevention of Delayed CINV
(Chemotherapy Induced Nausea and Vomiting) in
Patients Receiving Highly Emetogenic
Chemotherapy
Erectile
Dysfunction
RTOG R0831
Consent
QOL
Consent
HIPAA
Protocol
(temporary closure)
A Randomized,
Double-Blinded, Placebo-Controlled Phase III
Trial to Evaluate the Effectiveness of a
Phosphodiesterase 5 Inhibitor, Tadalafil, in
Prevention of Erectile Dysfunction in Patients
Treated With Radiotherapy for Prostate Cancer
Fatigue
NCCTG N07C2 Consent
HIPAA
Protocol
The Use of Wisconsin Ginseng (panax
quinquefolius) to Improve Cancer-Related
Fatigue: A Randomized, Double-Blind,
Placebo-Controlled Phase III Study
Hot Flashes
CTSU WFU97405
Consent
HIPAA
Protocol
(hold for Effexor
shortage)
Randomized Study of Soy Protein and Effexor on
Vasomotor Symptoms of Men with Prostate Cancer
Ovarian Function Failure
SWOG S0230
Consent
HIPAA Fast
Facts
Protocol
Phase III Trial of LHRH Analog Administration During
Chemotherapy to Reduce Ovarian Failure Following Standard Adjuvant Chemotherapy in Early
Stage, Hormone-Receptor Negative Breast Cancer
Bone
SWOG S0702
Consent
HIPAA
Fast Facts Protocol
A Prospective Observational Multicenter
Cohort Study to Assess the Incidence of
Osteonecrosis of the Jaw (ONJ) in Cancer
Patients with Bone Metastases Starting
Zoledronic Acid Treatment
CTSU C70604 Consent
HIPAA
Schema
Protocol
A Randomized, Phase III Study of Standard Dosing
versus Longer Dosing Interval of Zoledronic Acid
in Metastatic Cancer
Radiation
Oncology
RTOG R0517
Consent
HIPAA
Protocol
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
|
